Will Gilead find an antidote?
Gilead’s attempt to invalidate a US government patent hits a stumbling block, while a Chinese government entity seeks to patent its Coronavirus ‘cure’
Gilead Sciences has failed in its attempt to invalidate US government-owned patents related to HIV prevention, which it is
accused of infringing.
The rest of this document is only available to i-law.com online
If you are already a subscriber, please enter your details below to log in.